Celera Corporation (NASDAQ:CRA) is scheduled to speak at the 28th Annual JP Morgan Healthcare Conference on Tuesday, January 12. The company will be represented by its Chief Executive Officer Kathy Ordonez. Ms. Ordonez will begin her presentation at 4:30 pm PT that afternoon. Interested parties are invited to listen to a live webcast of the presentation at http://www.celera.com/. The webcast will be on the Media and Investors portion of the website and archived following the conclusion of the presentation. Live listeners are encouraged to log on fifteen minutes early to ensure a timely connection.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Celera Corporation (Celera) is a healthcare business delivering personalized disease management through a combination of products and services. The Company operates in three segments: a clinical laboratory testing service business (Lab Services), a products business (Products), and a segment which includes other activities under corporate management (Corporate). Its Lab Services business, conducted through Berkeley HeartLab, Inc., (BHL), offers a portfolio of clinical laboratory tests and disease management services to help healthcare providers improve cardiovascular disease treatment regimens for patients. Its Products business develops, manufactures, and oversees the commercialization of molecular diagnostic products, which are commercialized through its relationship with Abbott Molecular, a subsidiary of Abbott Laboratories. On July 1, 2008, Celera announced that it has completed its split-off from Applera Corporation.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
